Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$242.49 - $301.46 $838,530 - $1.04 Million
3,458 Added 0.7%
494,587 $122 Million
Q2 2022

Aug 15, 2022

BUY
$224.73 - $338.64 $10.3 Million - $15.5 Million
45,648 Added 10.25%
491,129 $122 Million
Q1 2022

May 16, 2022

SELL
$277.25 - $366.29 $7.83 Million - $10.3 Million
-28,248 Reduced 5.96%
445,481 $148 Million
Q4 2021

Feb 14, 2022

SELL
$300.63 - $371.35 $31 Million - $38.3 Million
-103,035 Reduced 17.86%
473,729 $170 Million
Q3 2021

Nov 15, 2021

SELL
$310.19 - $376.2 $11 Million - $13.4 Million
-35,619 Reduced 5.82%
576,764 $188 Million
Q2 2021

Aug 17, 2021

BUY
$262.71 - $351.17 $1.15 Million - $1.54 Million
4,388 Added 0.72%
612,383 $191 Million
Q1 2021

May 17, 2021

BUY
$285.92 - $355.13 $5.32 Million - $6.61 Million
18,622 Added 3.16%
607,995 $194 Million
Q4 2020

Feb 16, 2021

BUY
$251.88 - $324.2 $68.8 Million - $88.5 Million
272,990 Added 86.28%
589,373 $191 Million
Q3 2020

Nov 16, 2020

SELL
$255.22 - $317.0 $7.03 Million - $8.73 Million
-27,541 Reduced 8.01%
316,383 $87.7 Million
Q2 2020

Aug 14, 2020

SELL
$141.4 - $257.09 $7.98 Million - $14.5 Million
-56,458 Reduced 14.1%
343,924 $83.1 Million
Q1 2020

May 15, 2020

BUY
$130.51 - $196.01 $4.15 Million - $6.23 Million
31,784 Added 8.62%
400,382 $58.1 Million
Q4 2019

Feb 14, 2020

BUY
$159.31 - $223.54 $3.95 Million - $5.54 Million
24,802 Added 7.21%
368,598 $62.9 Million
Q3 2019

Nov 14, 2019

BUY
$175.89 - $279.23 $7.07 Million - $11.2 Million
40,181 Added 13.23%
343,796 $61.2 Million
Q2 2019

Aug 14, 2019

BUY
$250.96 - $284.94 $16.1 Million - $18.2 Million
64,014 Added 26.72%
303,615 $79.1 Million
Q1 2019

May 15, 2019

BUY
$276.39 - $362.25 $9.04 Million - $11.8 Million
32,702 Added 15.81%
239,601 $68.4 Million
Q4 2018

Feb 14, 2019

BUY
$281.08 - $444.25 $58.2 Million - $91.9 Million
206,899 New
206,899 $67.3 Million

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.